banner
    ROG.SW image

    Roche Holding AG

    ROG.SW

    258.1

    CHF
    +3.30
    (+1.30%)
    Day's range
    256.1
    261.1
    52 wk Range
    212.9
    313.8

    Key Statistics

    Previous Close
    254.8
    Open
    259.5
    Day's Range
    256.1 - 261.1
    52 wk Range
    212.9 - 313.8
    Volume
    1.17M
    Average Volume
    1.47M
    Market Cap
    205.71B
    Shares Outstanding
    797.03M
    Revenue
    62.40B
    Net Income
    8.28B
    EPS
    10.32
    P/E Value
    25.01
    Next Earnings Date
    Jul 24, 2025
    Dividend (Yield)
    3.72%
    Return on Assets
    10.43%
    Return on Equity
    34.98%
    Gross Profit Margin
    73.61%
    Price/Book
    6.56
    EBITDA
    16.62B
    EV/EBITDA (TTM)
    13.49
    P/BV Value
    6.56
    P/S Value
    3.48
    Beta
    0.216

    Roche Holding AG Company Profile

    Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. The company was founded in 1896 and is headquartered in Basel, Switzerland.

    Industry
    Drug Manufacturers - General
    Sector
    Healthcare
    Employes
    103249
    Market
    CH